Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADV7103 versus standard of care in distal renal tubular acidosis
2013-002988-25Phase 2Completed
- Sponsor
- Advicenne
- Start
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of Sibnayal in distal renal tubular acidosis (dRTA), sponsored by Advicenne. Primary endpoint: Average bicarbonate blood level during 3 days of treatment at steady state with ADV7103 and standard of care. Started Aug 2015; status: completed.
02
Drugs
Sibnayal
03
Conditions
distal renal tubular acidosis (dRTA)
Beyond the preview
Go deeper on 2013-002988-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002988-25.